Clinical Trial Update: Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating insulin-sensitizing NE3107 for improving sleep and fatigue in traumatic brain injury was terminated. The snippet does not provide tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• NE3107 (NE3107)

Snippet

Sponsor: Neurological Associates of West Los Angeles | Conditions: Traumatic Brain Injury | Phase 2 | Status: TERMINATED